SARS-COV-2 RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.617.1, Kappa)
nucleic-acid

SARS-COV-2 RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.617.1, Kappa)

EVAg
Produced by
: RKI
Shipping From
: Berlin - DE

Product Description

Ref-SKU:
009N-05274
SARS-COV-2 Lyophilised RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.617.1, Kappa). Extracted from infectious cell culture supernatant. Product only available via TNA.
Product Risk Group: 
RG1

Information on the related virus

ICTV Taxonomy: 
Riboviria / Orthornavirae / Pisuviricota / Pisoniviricetes / Nidovirales / Cornidovirineae / Coronaviridae / Orthocoronavirinae / Betacoronavirus / Sarbecovirus / Severe acute respiratory syndrome-related coronavirus
Virus name: 
SARS-CoV-2


Unit definition: 
1 vial of Lyophilised RNA

In stock

550,00 €
 (Cost per access for Academics)
Free access available

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

Cloned Product: No
Can it be used to produce GMO: 
No
Sequencing: 
Fully sequenced
Sequence checked: 
No
Mutations: 
No mutation compared to the reference sequence
Storage conditions: 
Freeze Dried (-20C)
Shipping conditions: 
Room Temperature
IATA Classification: 
NON DANGEROUS GOODS
Virus host type: 
Human virus

Information about the origin of the product

Recombinant product: 
No
Biological material origin: 
Natural origin
Collection date: 
Monday, 10 May, 2021
Country of collection: 
Germany